Hepatitis C drugs reduce liver-related deaths by nearly 50 percent: Study
by Press Release from Outbreak News Today on (#4N1GR)
A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer. The finding builds on a December 2018 study by the same researchers who found that antiviral drugs do not increase the risk of liver cancer ["]
The post Hepatitis C drugs reduce liver-related deaths by nearly 50 percent: Study appeared first on Outbreak News Today.